Transcat Announces Third Quarter Fiscal Year 2021 Conference Call and Webcast
Transcat, Inc. (Nasdaq: TRNS) will announce its third quarter fiscal year 2021 results after the market close on February 2, 2021. A conference call is scheduled for February 3, 2021, at 11:00 a.m. ET to discuss the financial outcomes and corporate strategies, with a subsequent Q&A session. The Company, a leader in calibration, repair, and inspection services, focuses on highly regulated industries, including Life Sciences, aerospace, and utilities. Its dual operating segments aim to drive organic sales growth and expand through acquisitions.
- Strong focus on highly regulated industries, enhancing revenue opportunities.
- Plans for organic growth and market expansion through acquisitions.
- None.
Transcat, Inc. (Nasdaq: TRNS) (“Transcat” or the “Company”), a leading provider of accredited calibration, repair, inspection and laboratory instrument services and value-added distributor of professional grade handheld test, measurement and control instrumentation, announced that it will release its third quarter fiscal year 2021 results after the close of financial markets on Tuesday, February 2, 2021.
The Company will host a conference call and webcast to review the financial and operating results for the period and discuss its corporate strategy and outlook. A question-and-answer session will follow.
Third Quarter Fiscal Year 2021 Conference Call
Wednesday, February 3, 2021
11:00 a.m. Eastern Time
Phone: 201-689-8471
Webcast and accompanying slide presentation: www.transcat.com/investor-relations
A telephonic replay will be available from 2:00 p.m. ET on the day of the teleconference call until Wednesday, February 10, 2021. To listen to the archived call, dial 412-317-6671 and enter conference ID number 13714787, or access the webcast replay at www.transcat.com/investor-relations, where a transcript will be posted once available.
ABOUT TRANSCAT
Transcat, Inc. is a leading provider of accredited calibration, repair, inspection and laboratory instrument services. The Company is focused on providing best-in-class services and products to highly regulated industries, particularly the Life Science industry, which includes pharmaceutical, biotechnology, medical device and other FDA-regulated businesses; as well as aerospace and defense, and energy and utilities. Transcat provides periodic on-site services, mobile calibration services, pickup and delivery, in-house services at its 22 Calibration Service Centers strategically located across the United States, Puerto Rico and Canada, and services at 20 imbedded customer-site locations. The breadth and depth of measurement parameters addressed by Transcat’s ISO/IEC 17025 scopes of accreditation are believed to be the best in the industry.
Transcat also operates as a leading value-added distributor that markets, sells and rents new and used national and proprietary brand instruments to customers primarily in North America. The Company believes its combined Service and Distribution segment offerings, experience, technical expertise and integrity create a unique and compelling value proposition for its customers.
Transcat’s strategy is to leverage the complementary nature of its two operating segments, its comprehensive service capabilities, strong brand, enhanced e-commerce capabilities and leading distribution platform to drive organic sales growth. The Company will also look to expand its addressable calibration market through acquisitions and capability investments to further realize the inherent leverage of its business model.
More information about Transcat can be found at: Transcat.com.
View source version on businesswire.com: https://www.businesswire.com/news/home/20210120005060/en/
FAQ
When will Transcat release its third quarter fiscal year 2021 results?
What is the date and time for the Transcat conference call?
Where can I find more information about Transcat's financial results?
What industries does Transcat focus on?
